Pharmacokinetic interactions between voriconazole and St John's wort and its modulation by genetic polymorphism of CYP2C19

Ähnliche Einträge

• Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics
  von: Rengelshausen, Jens, et al.
  Veröffentlicht: (2005)
• Pharmacokinetic interaction of macitentan with rivaroxaban and effect of CYP3A4 induction by St. John's Wort on the steady-state pharmacokinetics of macitentan and its active metabolite in healthy volunteers
  von: Werntz, Lars
  Veröffentlicht: (2018)
• Influence of St. John’s wort on the steadystate pharmacokinetics and metabolism of bosentan
  von: Markert, Christoph, et al.
  Veröffentlicht: (2014)
• The effect of induction of CYP3A4 by St John's Wort on ambrisentan plasma pharmacokinetics in volunteers of known CYP2C19 genotype
  von: Markert, Christoph, et al.
  Veröffentlicht: (2015)
• St. John’s wort treatment in women bears risks beyond pharmacokinetic drug interactions
  von: Hohmann, Nicolas, et al.
  Veröffentlicht: (2016)